IRS Weighs Easing Tax-Free Spinoff Rules in Boon to Tech, Pharma - McDermott Will & Emery

IRS Weighs Easing Tax-Free Spinoff Rules in Boon to Tech, Pharma

Overview


Jay Singer said that an Internal Revenue Service proposal would expand tax-favored spinoffs after several years of policies that made it more difficult for companies to execute these types of deals. “If you’re investing in a big, new product that takes seven or 10 years to develop, you can spend a whole lot of money and employ a whole lot of people and clearly be running a real business for a very long time before you ever have a dollar of revenue to show for it,” he said.